Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nhlh1
|
ENSMUSG00000051251.3 | nescient helix loop helix 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_172048552_172048746 | Nhlh1 | 8924 | 0.112965 | 0.90 | 2.7e-20 | Click! |
chr1_172047008_172047200 | Nhlh1 | 10469 | 0.111238 | 0.88 | 1.2e-18 | Click! |
chr1_172049306_172049831 | Nhlh1 | 8005 | 0.114329 | 0.87 | 5.0e-18 | Click! |
chr1_172053568_172053923 | Nhlh1 | 3828 | 0.135340 | 0.87 | 6.3e-18 | Click! |
chr1_172057571_172057962 | Nhlh1 | 193 | 0.899174 | 0.87 | 1.1e-17 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_16561093_16561486 | 74.31 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1070 |
0.53 |
chr9_62536098_62537614 | 41.03 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr10_79613505_79614566 | 39.85 |
C2cd4c |
C2 calcium-dependent domain containing 4C |
10 |
0.95 |
chr8_12947304_12948554 | 33.55 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr6_124915577_124916697 | 32.83 |
Ptms |
parathymosin |
608 |
0.37 |
chr11_4947352_4948069 | 30.98 |
Nefh |
neurofilament, heavy polypeptide |
354 |
0.82 |
chr9_112207779_112208199 | 30.83 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
9272 |
0.2 |
chr12_72069940_72071249 | 30.81 |
Gpr135 |
G protein-coupled receptor 135 |
531 |
0.72 |
chr13_92425671_92426978 | 30.61 |
Ankrd34b |
ankyrin repeat domain 34B |
17 |
0.95 |
chr3_92080488_92081161 | 29.88 |
Lor |
loricrin |
2318 |
0.17 |
chr9_8900765_8902148 | 29.63 |
Pgr |
progesterone receptor |
988 |
0.68 |
chr3_107479176_107479476 | 29.56 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
10621 |
0.18 |
chr7_79535477_79536145 | 29.16 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr1_3671269_3672324 | 28.63 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr13_83869057_83869227 | 28.40 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
22066 |
0.18 |
chr14_118925359_118925599 | 27.04 |
Dzip1 |
DAZ interacting protein 1 |
19 |
0.97 |
chr3_94363621_94364486 | 26.95 |
C2cd4d |
C2 calcium-dependent domain containing 4D |
1550 |
0.16 |
chr13_84059070_84059621 | 26.27 |
Gm17750 |
predicted gene, 17750 |
5427 |
0.24 |
chr14_7567758_7569131 | 25.89 |
Gm3558 |
predicted gene 3558 |
122 |
0.95 |
chr3_107479647_107479853 | 25.87 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
11045 |
0.17 |
chr7_62046082_62046717 | 25.81 |
Mir344f |
microRNA Mir344f |
151 |
0.94 |
chr6_91839831_91839982 | 25.65 |
Grip2 |
glutamate receptor interacting protein 2 |
12656 |
0.15 |
chr2_33215438_33216087 | 25.61 |
Angptl2 |
angiopoietin-like 2 |
307 |
0.87 |
chr3_127267961_127268143 | 25.39 |
Gm42972 |
predicted gene 42972 |
4237 |
0.16 |
chr10_79681206_79682337 | 24.97 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr18_8054510_8054913 | 24.97 |
Gm4833 |
predicted gene 4833 |
3508 |
0.33 |
chr8_45507619_45508001 | 24.76 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
2 |
0.98 |
chr8_40634456_40635069 | 24.75 |
Mtmr7 |
myotubularin related protein 7 |
3 |
0.98 |
chr18_12947284_12947832 | 24.68 |
Osbpl1a |
oxysterol binding protein-like 1A |
5717 |
0.19 |
chr3_158561021_158562021 | 24.48 |
Lrrc7 |
leucine rich repeat containing 7 |
176 |
0.97 |
chr6_55676658_55677265 | 24.42 |
Neurod6 |
neurogenic differentiation 6 |
4302 |
0.26 |
chr6_88981517_88981873 | 24.30 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
31012 |
0.14 |
chr8_78635037_78635192 | 24.27 |
Gm2253 |
predicted gene 2253 |
30820 |
0.18 |
chr5_34288113_34288876 | 24.16 |
Zfyve28 |
zinc finger, FYVE domain containing 28 |
45 |
0.57 |
chr10_67978939_67980119 | 24.04 |
Rtkn2 |
rhotekin 2 |
41 |
0.98 |
chr14_3208167_3209194 | 23.93 |
D830030K20Rik |
RIKEN cDNA D830030K20 gene |
103 |
0.95 |
chr1_38835547_38836894 | 23.79 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr4_58943371_58943812 | 23.55 |
Zkscan16 |
zinc finger with KRAB and SCAN domains 16 |
37 |
0.97 |
chr14_5961062_5962084 | 23.24 |
Gm3248 |
predicted gene 3248 |
172 |
0.91 |
chr13_59011549_59011989 | 22.78 |
Gm34245 |
predicted gene, 34245 |
66527 |
0.09 |
chr7_4119309_4120004 | 22.49 |
Ttyh1 |
tweety family member 1 |
34 |
0.91 |
chr2_74426718_74427115 | 22.45 |
Lnpk |
lunapark, ER junction formation factor |
106190 |
0.05 |
chr4_47091686_47092366 | 22.38 |
Galnt12 |
polypeptide N-acetylgalactosaminyltransferase 12 |
103 |
0.96 |
chr14_55520440_55521261 | 22.36 |
Nrl |
neural retina leucine zipper gene |
417 |
0.62 |
chr4_97418604_97418964 | 22.20 |
Gm12696 |
predicted gene 12696 |
103548 |
0.08 |
chr17_85950005_85950172 | 22.16 |
Gm30117 |
predicted gene, 30117 |
21509 |
0.24 |
chr5_108549866_108550582 | 22.09 |
Cplx1 |
complexin 1 |
200 |
0.9 |
chr6_104492817_104492984 | 22.00 |
Cntn6 |
contactin 6 |
22 |
0.99 |
chr17_27679167_27679824 | 21.72 |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
5686 |
0.12 |
chr7_119184201_119185061 | 21.68 |
Gpr139 |
G protein-coupled receptor 139 |
28 |
0.98 |
chr15_73645198_73646275 | 21.58 |
Slc45a4 |
solute carrier family 45, member 4 |
26 |
0.6 |
chr13_116309603_116310279 | 21.36 |
Isl1 |
ISL1 transcription factor, LIM/homeodomain |
252 |
0.94 |
chr5_37163228_37163473 | 21.29 |
Gm1043 |
predicted gene 1043 |
501 |
0.8 |
chr3_19566788_19567409 | 21.15 |
Gm23330 |
predicted gene, 23330 |
6845 |
0.18 |
chr7_63444022_63445137 | 21.12 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr14_70659174_70659883 | 21.10 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr19_46523220_46524148 | 21.08 |
Trim8 |
tripartite motif-containing 8 |
9024 |
0.15 |
chr8_12873206_12874084 | 21.08 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr10_81025274_81025586 | 21.01 |
Diras1 |
DIRAS family, GTP-binding RAS-like 1 |
21 |
0.82 |
chr4_45184399_45185347 | 21.00 |
Frmpd1 |
FERM and PDZ domain containing 1 |
2 |
0.98 |
chr12_111693687_111693960 | 20.94 |
Gm36635 |
predicted gene, 36635 |
9259 |
0.09 |
chr14_123626303_123627238 | 20.83 |
Nalcn |
sodium leak channel, non-selective |
106 |
0.98 |
chr2_165563196_165563907 | 20.72 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
31481 |
0.13 |
chr16_65815403_65815951 | 20.70 |
Vgll3 |
vestigial like family member 3 |
48 |
0.98 |
chr2_44696571_44696739 | 20.64 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
59782 |
0.15 |
chr14_61172444_61173564 | 20.62 |
Sacs |
sacsin |
14 |
0.98 |
chr3_66325480_66326023 | 20.60 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
28914 |
0.18 |
chr19_47014440_47014752 | 20.50 |
Ina |
internexin neuronal intermediate filament protein, alpha |
102 |
0.87 |
chr9_45663652_45664379 | 20.48 |
Dscaml1 |
DS cell adhesion molecule like 1 |
8822 |
0.19 |
chr11_32106427_32106633 | 20.40 |
Gm12108 |
predicted gene 12108 |
5302 |
0.22 |
chr5_111220876_111221370 | 20.33 |
Ttc28 |
tetratricopeptide repeat domain 28 |
4335 |
0.22 |
chr7_79572141_79572757 | 20.28 |
Gm45168 |
predicted gene 45168 |
6619 |
0.1 |
chr5_24482511_24483721 | 20.27 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
2944 |
0.12 |
chr7_37439583_37439757 | 20.24 |
Gm44806 |
predicted gene 44806 |
27752 |
0.18 |
chr4_20777672_20778960 | 20.07 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr14_4018192_4019443 | 20.06 |
Gm5796 |
predicted gene 5796 |
5124 |
0.14 |
chr12_16643779_16644298 | 20.06 |
Lpin1 |
lipin 1 |
2928 |
0.23 |
chr7_84409236_84410328 | 19.95 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr4_134430506_134430992 | 19.93 |
1700021N21Rik |
RIKEN cDNA 1700021N21 gene |
19422 |
0.1 |
chr10_52022610_52022833 | 19.91 |
Vgll2 |
vestigial like family member 2 |
219 |
0.92 |
chr4_91374952_91375142 | 19.91 |
Elavl2 |
ELAV like RNA binding protein 1 |
1260 |
0.39 |
chr10_87492542_87493159 | 19.78 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
810 |
0.64 |
chr3_93446951_93447770 | 19.48 |
Tchh |
trichohyalin |
5030 |
0.1 |
chr16_28445903_28447087 | 19.44 |
Fgf12 |
fibroblast growth factor 12 |
218 |
0.97 |
chr15_71727617_71728041 | 19.38 |
Fam135b |
family with sequence similarity 135, member B |
9 |
0.98 |
chr8_31091237_31091775 | 19.27 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
144 |
0.96 |
chr7_34570196_34571084 | 19.27 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr5_15850216_15850406 | 19.26 |
Gm42453 |
predicted gene 42453 |
19936 |
0.14 |
chr10_26695225_26695646 | 19.19 |
Gm48893 |
predicted gene, 48893 |
139 |
0.96 |
chr10_24595329_24596330 | 19.00 |
Gm15270 |
predicted gene 15270 |
12 |
0.52 |
chr5_37162967_37163149 | 18.95 |
Gm1043 |
predicted gene 1043 |
209 |
0.94 |
chr3_8510910_8511440 | 18.88 |
Stmn2 |
stathmin-like 2 |
1589 |
0.43 |
chr2_153071972_153072126 | 18.82 |
Ccm2l |
cerebral cavernous malformation 2-like |
6047 |
0.15 |
chr18_5978462_5978815 | 18.72 |
Gm34804 |
predicted gene, 34804 |
33455 |
0.17 |
chr9_92930513_92930898 | 18.65 |
Gm28054 |
predicted gene 28054 |
34873 |
0.17 |
chr2_127521161_127522051 | 18.60 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr12_105899327_105899513 | 18.59 |
Gm19554 |
predicted gene, 19554 |
421 |
0.84 |
chr13_96131942_96132235 | 18.57 |
Sv2c |
synaptic vesicle glycoprotein 2c |
489 |
0.69 |
chr5_146713132_146713362 | 18.52 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
6625 |
0.19 |
chr8_122284023_122284944 | 18.47 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chr4_138325465_138326730 | 18.39 |
Gm27646 |
predicted gene, 27646 |
8 |
0.64 |
chr10_43106136_43106524 | 18.34 |
Gm29245 |
predicted gene 29245 |
47886 |
0.11 |
chr4_23982818_23983489 | 18.33 |
Gm28448 |
predicted gene 28448 |
49199 |
0.19 |
chr1_22533152_22534195 | 18.25 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
21144 |
0.28 |
chr7_79525641_79525821 | 18.24 |
Mir9-3hg |
Mir9-3 host gene |
2119 |
0.16 |
chr12_73241990_73242324 | 18.21 |
Trmt5 |
TRM5 tRNA methyltransferase 5 |
40514 |
0.14 |
chr4_116016940_116018214 | 18.20 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr9_41889978_41890642 | 18.11 |
Gm40513 |
predicted gene, 40513 |
294 |
0.89 |
chr9_41378019_41378386 | 18.07 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1641 |
0.36 |
chr4_13480505_13480805 | 18.04 |
Gm11826 |
predicted gene 11826 |
2537 |
0.36 |
chr4_45819207_45819704 | 17.99 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
3092 |
0.2 |
chr1_84695758_84696417 | 17.97 |
Dner |
delta/notch-like EGF repeat containing |
68 |
0.74 |
chr13_83721104_83721451 | 17.97 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
104 |
0.95 |
chr10_62110939_62111480 | 17.95 |
Fam241b |
family with sequence similarity 241, member B |
159 |
0.95 |
chr5_102373723_102373883 | 17.92 |
Gm42932 |
predicted gene 42932 |
42400 |
0.18 |
chr10_89872924_89873647 | 17.86 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
224 |
0.95 |
chr11_29774406_29774599 | 17.84 |
Eml6 |
echinoderm microtubule associated protein like 6 |
10269 |
0.17 |
chr12_111758304_111760062 | 17.82 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr14_6889264_6890534 | 17.79 |
Gm3667 |
predicted gene 3667 |
63 |
0.97 |
chr4_101508891_101509449 | 17.77 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
1140 |
0.54 |
chr19_36553934_36555231 | 17.76 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr2_151740625_151741514 | 17.76 |
Psmf1 |
proteasome (prosome, macropain) inhibitor subunit 1 |
224 |
0.9 |
chr14_12338097_12338549 | 17.74 |
Gm24578 |
predicted gene, 24578 |
4419 |
0.14 |
chr9_61530285_61530668 | 17.53 |
Gm34424 |
predicted gene, 34424 |
2939 |
0.32 |
chr3_109782232_109782939 | 17.50 |
Ntng1 |
netrin G1 |
50674 |
0.16 |
chr9_53705535_53706804 | 17.48 |
Rab39 |
RAB39, member RAS oncogene family |
63 |
0.96 |
chr12_70680124_70680305 | 17.48 |
Gm32369 |
predicted gene, 32369 |
1636 |
0.31 |
chr1_136142237_136142876 | 17.48 |
Kif21b |
kinesin family member 21B |
11102 |
0.11 |
chr2_180854741_180854913 | 17.47 |
Gm14339 |
predicted gene 14339 |
7175 |
0.11 |
chr7_12779870_12780809 | 17.47 |
Zscan18 |
zinc finger and SCAN domain containing 18 |
315 |
0.58 |
chr7_99267195_99268129 | 17.45 |
Map6 |
microtubule-associated protein 6 |
173 |
0.76 |
chr5_30712274_30713396 | 17.36 |
Dpysl5 |
dihydropyrimidinase-like 5 |
934 |
0.49 |
chr16_16561514_16561689 | 17.30 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1382 |
0.44 |
chrX_143543266_143543620 | 17.29 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr9_124439906_124440949 | 17.24 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr3_105585758_105586171 | 17.24 |
Kcnd3 |
potassium voltage-gated channel, Shal-related family, member 3 |
83041 |
0.07 |
chr2_28446566_28447382 | 17.16 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
108 |
0.95 |
chr4_148327377_148327851 | 17.12 |
Gm13206 |
predicted gene 13206 |
20761 |
0.14 |
chr1_92910895_92912569 | 17.08 |
Rnpepl1 |
arginyl aminopeptidase (aminopeptidase B)-like 1 |
523 |
0.52 |
chr1_88924043_88924538 | 17.03 |
Gm4753 |
predicted gene 4753 |
8029 |
0.23 |
chr19_61225302_61226760 | 17.00 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr4_120277239_120277533 | 16.95 |
Foxo6 |
forkhead box O6 |
9963 |
0.21 |
chr4_9859459_9860339 | 16.83 |
Gdf6 |
growth differentiation factor 6 |
15527 |
0.22 |
chr3_92081181_92081919 | 16.79 |
Lor |
loricrin |
1592 |
0.24 |
chr17_48999548_48999943 | 16.77 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
67366 |
0.11 |
chr8_4210272_4211025 | 16.77 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
3766 |
0.1 |
chr18_36017856_36019112 | 16.71 |
Nrg2 |
neuregulin 2 |
13457 |
0.16 |
chr7_75329116_75329290 | 16.70 |
Sv2b |
synaptic vesicle glycoprotein 2 b |
19941 |
0.17 |
chr6_82939285_82939948 | 16.70 |
Sema4f |
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
71 |
0.94 |
chr11_54303609_54304215 | 16.66 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
93 |
0.96 |
chr9_75610973_75611679 | 16.63 |
Tmod2 |
tropomodulin 2 |
1 |
0.97 |
chr13_10360181_10360716 | 16.62 |
Chrm3 |
cholinergic receptor, muscarinic 3, cardiac |
115 |
0.97 |
chrX_133688279_133688924 | 16.58 |
Pcdh19 |
protocadherin 19 |
386 |
0.92 |
chr17_68841123_68841681 | 16.57 |
Gm49949 |
predicted gene, 49949 |
2623 |
0.24 |
chr4_21930986_21931430 | 16.57 |
Faxc |
failed axon connections homolog |
121 |
0.97 |
chr1_93227325_93227654 | 16.45 |
Sned1 |
sushi, nidogen and EGF-like domains 1 |
8352 |
0.14 |
chr8_36142092_36142588 | 16.44 |
Gm38414 |
predicted gene, 38414 |
13670 |
0.15 |
chr4_91371091_91372260 | 16.43 |
Elavl2 |
ELAV like RNA binding protein 1 |
281 |
0.88 |
chr16_45724762_45725141 | 16.39 |
Tagln3 |
transgelin 3 |
343 |
0.83 |
chr17_27203606_27204996 | 16.36 |
Lemd2 |
LEM domain containing 2 |
168 |
0.9 |
chr2_25319011_25319403 | 16.35 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
20 |
0.93 |
chr14_4334095_4335404 | 16.29 |
2610042L04Rik |
RIKEN cDNA 2610042L04 gene |
14 |
0.97 |
chr18_83523941_83524284 | 16.29 |
Gm50416 |
predicted gene, 50416 |
1192 |
0.46 |
chr13_112100671_112101178 | 16.25 |
Gm31104 |
predicted gene, 31104 |
37192 |
0.15 |
chr17_9167143_9167467 | 16.21 |
6530411M01Rik |
RIKEN cDNA 6530411M01 gene |
531 |
0.8 |
chr5_149489128_149489325 | 16.20 |
Gm2566 |
predicted gene 2566 |
13826 |
0.12 |
chr15_74672233_74673425 | 16.19 |
Arc |
activity regulated cytoskeletal-associated protein |
259 |
0.85 |
chr7_109493646_109494020 | 16.15 |
Trim66 |
tripartite motif-containing 66 |
95 |
0.95 |
chr10_42477881_42479089 | 16.15 |
Afg1l |
AFG1 like ATPase |
70 |
0.97 |
chr9_83805509_83806110 | 16.13 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
443 |
0.84 |
chr3_8830969_8831121 | 16.10 |
Gm15467 |
predicted gene 15467 |
50154 |
0.11 |
chr1_42703489_42704501 | 16.06 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr18_11892775_11892946 | 16.04 |
Gm49968 |
predicted gene, 49968 |
20271 |
0.17 |
chr4_155345224_155345890 | 16.02 |
Prkcz |
protein kinase C, zeta |
175 |
0.92 |
chr14_124192585_124192818 | 16.02 |
Fgf14 |
fibroblast growth factor 14 |
201 |
0.97 |
chrX_103533421_103533606 | 15.99 |
Gm9157 |
predicted gene 9157 |
4030 |
0.09 |
chr16_30308519_30309364 | 15.98 |
Gp5 |
glycoprotein 5 (platelet) |
1838 |
0.29 |
chr18_25590199_25590989 | 15.87 |
Gm3227 |
predicted gene 3227 |
6896 |
0.29 |
chr4_75561854_75562168 | 15.86 |
Gm11259 |
predicted gene 11259 |
181251 |
0.03 |
chr14_54912471_54913268 | 15.86 |
Slc22a17 |
solute carrier family 22 (organic cation transporter), member 17 |
21 |
0.93 |
chr8_71628994_71630252 | 15.81 |
Mir6769b |
microRNA 6769b |
1483 |
0.21 |
chr15_75566838_75567525 | 15.73 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
35 |
0.96 |
chr6_5380590_5380838 | 15.69 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
2672 |
0.34 |
chr1_14755119_14756069 | 15.67 |
Gm9947 |
predicted gene 9947 |
140 |
0.64 |
chr6_138420273_138420927 | 15.62 |
Lmo3 |
LIM domain only 3 |
852 |
0.59 |
chr16_9281007_9281201 | 15.56 |
Gm49451 |
predicted gene, 49451 |
122334 |
0.06 |
chr9_103146716_103147058 | 15.55 |
Gm37166 |
predicted gene, 37166 |
26519 |
0.13 |
chr3_131054299_131054567 | 15.52 |
A430072C10Rik |
RIKEN cDNA A430072C10 gene |
28063 |
0.15 |
chr16_41510930_41511158 | 15.51 |
Lsamp |
limbic system-associated membrane protein |
21814 |
0.26 |
chr14_6287027_6287952 | 15.50 |
Gm3411 |
predicted gene 3411 |
239 |
0.89 |
chr16_38924994_38925169 | 15.49 |
Gm22500 |
predicted gene, 22500 |
2128 |
0.33 |
chr1_42491113_42491583 | 15.45 |
Gm37047 |
predicted gene, 37047 |
465 |
0.88 |
chr7_48137248_48137604 | 15.44 |
Gm28665 |
predicted gene 28665 |
19985 |
0.11 |
chr4_128715231_128715603 | 15.41 |
Phc2 |
polyhomeotic 2 |
5253 |
0.21 |
chr5_71976591_71976789 | 15.40 |
Gm15617 |
predicted gene 15617 |
56798 |
0.14 |
chrX_142390195_142391160 | 15.39 |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
142 |
0.95 |
chr16_37584223_37584651 | 15.38 |
Hgd |
homogentisate 1, 2-dioxygenase |
4155 |
0.17 |
chr9_116807725_116808119 | 15.34 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
14884 |
0.3 |
chr1_154726696_154727096 | 15.34 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
540 |
0.87 |
chr2_181134637_181135435 | 15.31 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
91 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.6 | 52.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
16.5 | 49.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
14.0 | 42.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
10.9 | 43.7 | GO:0030035 | microspike assembly(GO:0030035) |
10.9 | 32.6 | GO:0021586 | pons maturation(GO:0021586) |
10.0 | 20.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
9.7 | 29.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
9.1 | 72.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
8.4 | 25.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
8.3 | 24.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
7.8 | 31.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
7.7 | 30.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
7.6 | 22.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
7.6 | 22.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
7.5 | 22.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
7.5 | 7.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
7.5 | 22.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
7.1 | 28.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
7.1 | 42.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
7.1 | 35.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
7.0 | 28.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
6.9 | 6.9 | GO:0061205 | paramesonephric duct development(GO:0061205) |
6.9 | 20.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
6.7 | 46.8 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
6.4 | 12.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
6.4 | 19.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
6.3 | 25.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
6.3 | 25.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
6.1 | 6.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
6.1 | 18.3 | GO:0030070 | insulin processing(GO:0030070) |
6.1 | 30.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
6.0 | 12.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
5.9 | 5.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
5.9 | 17.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
5.9 | 29.5 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
5.8 | 5.8 | GO:0021550 | medulla oblongata development(GO:0021550) |
5.8 | 17.4 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
5.7 | 11.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
5.6 | 11.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
5.6 | 22.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
5.6 | 16.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
5.6 | 11.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
5.6 | 16.8 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
5.6 | 11.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
5.6 | 22.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
5.4 | 16.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
5.4 | 10.9 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
5.4 | 113.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
5.4 | 32.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
5.3 | 15.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
5.3 | 5.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
5.2 | 41.9 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
5.2 | 15.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
5.2 | 103.2 | GO:0008038 | neuron recognition(GO:0008038) |
5.1 | 15.4 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
5.1 | 15.3 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
5.0 | 15.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
5.0 | 5.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
4.9 | 14.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
4.9 | 102.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
4.8 | 19.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
4.7 | 4.7 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
4.7 | 9.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
4.7 | 18.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.6 | 9.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
4.6 | 13.9 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
4.6 | 41.7 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
4.6 | 13.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
4.5 | 18.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
4.5 | 40.5 | GO:0050957 | equilibrioception(GO:0050957) |
4.5 | 17.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
4.5 | 13.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
4.4 | 8.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
4.4 | 8.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
4.4 | 13.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
4.3 | 13.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
4.3 | 51.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
4.3 | 17.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
4.3 | 12.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
4.2 | 12.7 | GO:0001927 | exocyst assembly(GO:0001927) |
4.2 | 12.7 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
4.2 | 12.7 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
4.2 | 8.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
4.1 | 8.3 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
4.1 | 24.7 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
4.1 | 12.3 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
4.1 | 16.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
4.1 | 12.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
4.1 | 28.7 | GO:0060513 | prostatic bud formation(GO:0060513) |
4.1 | 8.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
4.1 | 16.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
4.1 | 8.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
4.0 | 36.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
4.0 | 12.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
4.0 | 27.9 | GO:0071625 | vocalization behavior(GO:0071625) |
4.0 | 8.0 | GO:0014028 | notochord formation(GO:0014028) |
4.0 | 7.9 | GO:0046959 | habituation(GO:0046959) |
3.9 | 11.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.9 | 15.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
3.9 | 11.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
3.9 | 11.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
3.9 | 38.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
3.9 | 3.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
3.8 | 3.8 | GO:0014819 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of skeletal muscle contraction(GO:0014819) |
3.8 | 30.6 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
3.8 | 26.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
3.8 | 60.5 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
3.8 | 11.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
3.8 | 37.6 | GO:0022038 | corpus callosum development(GO:0022038) |
3.7 | 11.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
3.7 | 22.0 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
3.7 | 7.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
3.6 | 14.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
3.6 | 7.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
3.5 | 21.3 | GO:0048840 | otolith development(GO:0048840) |
3.5 | 3.5 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.5 | 14.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
3.5 | 10.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
3.5 | 3.5 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
3.5 | 10.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
3.4 | 6.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
3.4 | 17.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
3.4 | 51.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
3.4 | 6.8 | GO:0061743 | motor learning(GO:0061743) |
3.4 | 6.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
3.4 | 6.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
3.4 | 3.4 | GO:0009629 | response to gravity(GO:0009629) |
3.4 | 6.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
3.3 | 13.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.3 | 169.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.3 | 20.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
3.3 | 6.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
3.3 | 3.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
3.3 | 3.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
3.3 | 13.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
3.3 | 9.8 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
3.2 | 16.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
3.2 | 9.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
3.2 | 12.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
3.2 | 6.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.2 | 12.7 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
3.2 | 22.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
3.2 | 9.5 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
3.1 | 12.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
3.1 | 6.1 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
3.1 | 15.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
3.0 | 12.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
3.0 | 18.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
3.0 | 3.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
3.0 | 9.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
3.0 | 9.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
3.0 | 35.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.9 | 14.7 | GO:0090383 | phagosome acidification(GO:0090383) |
2.9 | 8.8 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.9 | 2.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.9 | 8.7 | GO:1901656 | glycoside transport(GO:1901656) |
2.9 | 11.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
2.9 | 8.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.8 | 14.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.8 | 8.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.8 | 11.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.8 | 5.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
2.8 | 11.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.8 | 11.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.7 | 8.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
2.7 | 11.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.7 | 8.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
2.7 | 5.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.7 | 10.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
2.7 | 21.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.7 | 8.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
2.7 | 5.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
2.7 | 10.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
2.7 | 8.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
2.7 | 2.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
2.6 | 18.5 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.6 | 2.6 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
2.6 | 10.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
2.6 | 2.6 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
2.6 | 41.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
2.6 | 2.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
2.6 | 12.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
2.6 | 35.7 | GO:0001964 | startle response(GO:0001964) |
2.5 | 7.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.5 | 10.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
2.5 | 12.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.5 | 5.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.5 | 7.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.5 | 7.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
2.5 | 4.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.4 | 7.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.4 | 41.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
2.4 | 4.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
2.4 | 4.8 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
2.4 | 4.8 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
2.4 | 2.4 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
2.4 | 4.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.4 | 23.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
2.4 | 9.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.4 | 2.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
2.4 | 16.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
2.4 | 25.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
2.3 | 4.7 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
2.3 | 9.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
2.3 | 7.0 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
2.3 | 4.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.3 | 4.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
2.3 | 9.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
2.3 | 6.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
2.3 | 6.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
2.3 | 13.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
2.3 | 27.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
2.3 | 2.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
2.3 | 2.3 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.3 | 18.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
2.3 | 6.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.3 | 6.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
2.2 | 4.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.2 | 11.2 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
2.2 | 6.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
2.2 | 6.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.2 | 24.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
2.2 | 6.7 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
2.2 | 4.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.2 | 140.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
2.2 | 4.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.2 | 8.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
2.1 | 6.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
2.1 | 6.4 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
2.1 | 19.0 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
2.1 | 6.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
2.1 | 4.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.1 | 4.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.1 | 6.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.1 | 14.5 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
2.1 | 2.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
2.1 | 2.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.0 | 4.1 | GO:1903416 | response to glycoside(GO:1903416) |
2.0 | 4.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
2.0 | 10.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.0 | 6.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
2.0 | 12.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
2.0 | 2.0 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
2.0 | 11.9 | GO:0030432 | peristalsis(GO:0030432) |
2.0 | 4.0 | GO:0090427 | activation of meiosis(GO:0090427) |
2.0 | 5.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
2.0 | 3.9 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
2.0 | 5.9 | GO:0060179 | male mating behavior(GO:0060179) |
2.0 | 3.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.0 | 2.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
2.0 | 5.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.9 | 11.6 | GO:0015884 | folic acid transport(GO:0015884) |
1.9 | 17.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.9 | 9.6 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.9 | 7.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.9 | 11.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.9 | 13.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.9 | 9.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
1.9 | 5.7 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.9 | 9.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.9 | 7.5 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.9 | 11.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.9 | 14.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.9 | 5.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.9 | 3.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.8 | 1.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.8 | 9.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.8 | 23.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
1.8 | 12.7 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.8 | 9.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
1.8 | 16.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.8 | 1.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.8 | 12.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.7 | 3.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.7 | 5.2 | GO:0042637 | catagen(GO:0042637) |
1.7 | 5.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.7 | 1.7 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.7 | 3.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.7 | 25.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.7 | 1.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.7 | 5.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.7 | 16.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.7 | 5.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.7 | 5.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.7 | 3.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.7 | 5.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.7 | 8.4 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
1.7 | 1.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.7 | 6.7 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.7 | 3.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.7 | 36.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.7 | 5.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.6 | 4.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.6 | 4.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.6 | 4.9 | GO:0060004 | reflex(GO:0060004) |
1.6 | 14.7 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.6 | 4.9 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
1.6 | 16.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.6 | 4.9 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
1.6 | 9.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.6 | 25.8 | GO:0019228 | neuronal action potential(GO:0019228) |
1.6 | 3.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.6 | 6.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
1.6 | 1.6 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
1.6 | 22.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
1.6 | 11.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.6 | 3.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.6 | 6.3 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
1.6 | 1.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
1.6 | 10.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.6 | 4.7 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
1.5 | 9.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.5 | 9.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.5 | 6.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.5 | 6.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.5 | 3.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.5 | 6.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
1.5 | 6.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
1.5 | 7.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.5 | 4.5 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
1.5 | 4.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.5 | 3.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.5 | 4.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.4 | 2.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 2.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.4 | 5.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.4 | 5.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.4 | 5.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
1.4 | 19.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.4 | 1.4 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
1.4 | 2.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.4 | 4.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.4 | 2.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.4 | 4.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.4 | 5.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.4 | 9.6 | GO:0060736 | prostate gland growth(GO:0060736) |
1.4 | 1.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
1.4 | 1.4 | GO:0090135 | actin filament branching(GO:0090135) |
1.4 | 9.5 | GO:0060914 | heart formation(GO:0060914) |
1.4 | 28.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.3 | 4.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.3 | 16.2 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
1.3 | 16.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.3 | 4.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.3 | 5.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.3 | 2.7 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.3 | 4.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.3 | 6.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.3 | 1.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.3 | 5.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.3 | 2.6 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
1.3 | 2.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.3 | 2.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.3 | 2.6 | GO:1900449 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
1.3 | 2.6 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
1.3 | 1.3 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
1.3 | 17.8 | GO:0007416 | synapse assembly(GO:0007416) |
1.3 | 3.8 | GO:0001975 | response to amphetamine(GO:0001975) |
1.3 | 3.8 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
1.3 | 2.5 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.3 | 3.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
1.3 | 12.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.3 | 5.0 | GO:0060013 | righting reflex(GO:0060013) |
1.3 | 16.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.3 | 20.0 | GO:0071475 | cellular response to salt stress(GO:0071472) cellular hyperosmotic salinity response(GO:0071475) |
1.2 | 7.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 3.7 | GO:0050955 | thermoception(GO:0050955) |
1.2 | 14.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
1.2 | 6.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.2 | 8.7 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
1.2 | 158.6 | GO:0006813 | potassium ion transport(GO:0006813) |
1.2 | 7.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.2 | 2.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.2 | 7.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.2 | 7.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.2 | 3.6 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
1.2 | 8.4 | GO:0060384 | innervation(GO:0060384) |
1.2 | 2.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
1.2 | 1.2 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
1.2 | 2.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.2 | 12.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.2 | 4.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.2 | 4.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.2 | 4.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.2 | 4.6 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.2 | 3.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.2 | 1.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.1 | 3.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.1 | 1.1 | GO:0060594 | mammary gland specification(GO:0060594) |
1.1 | 3.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.1 | 9.1 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
1.1 | 2.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.1 | 5.7 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
1.1 | 2.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
1.1 | 3.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.1 | 2.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.1 | 6.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.1 | 1.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
1.1 | 2.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
1.1 | 2.2 | GO:0061055 | myotome development(GO:0061055) |
1.1 | 2.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.1 | 4.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
1.1 | 4.4 | GO:0051639 | actin filament network formation(GO:0051639) |
1.1 | 3.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.1 | 9.8 | GO:0006983 | ER overload response(GO:0006983) |
1.1 | 5.4 | GO:0015808 | L-alanine transport(GO:0015808) |
1.1 | 4.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.1 | 2.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.1 | 3.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.1 | 4.2 | GO:0060074 | synapse maturation(GO:0060074) |
1.1 | 6.4 | GO:0021854 | hypothalamus development(GO:0021854) |
1.1 | 3.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
1.0 | 2.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
1.0 | 3.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.0 | 3.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.0 | 8.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.0 | 6.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.0 | 9.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.0 | 1.0 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
1.0 | 2.0 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
1.0 | 1.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.0 | 20.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
1.0 | 1.0 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
1.0 | 3.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.0 | 9.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.0 | 1.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
1.0 | 4.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 6.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.0 | 1.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.0 | 1.0 | GO:0021764 | amygdala development(GO:0021764) |
1.0 | 2.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.0 | 3.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.0 | 6.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.0 | 1.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.0 | 1.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.0 | 3.8 | GO:0035627 | ceramide transport(GO:0035627) |
1.0 | 3.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.0 | 1.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.0 | 5.7 | GO:0051231 | spindle elongation(GO:0051231) |
0.9 | 0.9 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.9 | 7.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 4.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.9 | 2.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.9 | 4.7 | GO:0031652 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.9 | 5.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.9 | 2.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.9 | 2.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.9 | 4.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.9 | 1.9 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.9 | 1.8 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.9 | 4.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.9 | 11.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.9 | 2.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.9 | 4.5 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.9 | 5.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.9 | 4.5 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.9 | 58.5 | GO:0001764 | neuron migration(GO:0001764) |
0.9 | 1.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.9 | 2.6 | GO:0060068 | vagina development(GO:0060068) |
0.9 | 1.8 | GO:0070141 | response to UV-A(GO:0070141) |
0.9 | 6.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.9 | 3.5 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.9 | 1.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.9 | 11.2 | GO:0006415 | translational termination(GO:0006415) |
0.9 | 4.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.9 | 0.9 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.9 | 3.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.9 | 0.9 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.9 | 0.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.9 | 1.7 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.8 | 2.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.8 | 2.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.8 | 1.7 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.8 | 1.7 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 3.4 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.8 | 1.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.8 | 0.8 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.8 | 2.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.8 | 4.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.8 | 9.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.8 | 14.1 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.8 | 0.8 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.8 | 2.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.8 | 3.3 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 4.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.8 | 1.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.8 | 2.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.8 | 4.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.8 | 8.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.8 | 5.6 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.8 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.8 | 3.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.8 | 1.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 2.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.8 | 1.6 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.8 | 2.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.8 | 2.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.8 | 0.8 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.8 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.8 | 6.1 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.8 | 2.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.8 | 0.8 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.8 | 5.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.8 | 2.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.8 | 0.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.8 | 3.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 1.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.7 | 1.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.7 | 1.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.7 | 22.9 | GO:0046847 | filopodium assembly(GO:0046847) |
0.7 | 1.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.7 | 3.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.7 | 3.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 3.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.7 | 2.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 2.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.7 | 2.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.7 | 2.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.7 | 2.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 6.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.7 | 2.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.7 | 2.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.7 | 2.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.7 | 1.4 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.7 | 9.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.7 | 3.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 3.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.7 | 2.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.7 | 17.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.7 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.7 | 2.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.7 | 3.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 3.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.7 | 0.7 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.7 | 2.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.7 | 6.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.7 | 3.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.7 | 0.7 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.7 | 2.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.7 | 3.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.7 | 2.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.7 | 1.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.7 | 5.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.7 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.7 | 5.9 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.7 | 0.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.7 | 0.7 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.6 | 5.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 1.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 0.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 5.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.6 | 1.3 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.6 | 1.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.6 | 0.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.6 | 1.8 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 1.8 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) positive regulation of tumor necrosis factor secretion(GO:1904469) tumor necrosis factor secretion(GO:1990774) |
0.6 | 1.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 2.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.6 | 1.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.6 | 44.3 | GO:0016358 | dendrite development(GO:0016358) |
0.6 | 1.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.6 | 1.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.6 | 12.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.6 | 1.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 1.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.6 | 2.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.6 | 2.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.6 | 1.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 2.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.6 | 4.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.6 | 7.5 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.6 | 5.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.6 | 1.1 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 2.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.6 | 2.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.6 | 2.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 1.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.6 | 1.7 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.6 | 2.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.6 | 9.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.6 | 1.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 1.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 0.6 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.5 | 1.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 15.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.5 | 0.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 0.5 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 1.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 4.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 1.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 1.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 2.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 2.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.5 | 3.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.5 | 7.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.5 | 0.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.5 | 1.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 4.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.5 | 2.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.5 | 2.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.5 | 1.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.5 | 1.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.5 | 1.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 2.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.5 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 2.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 3.0 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.5 | 1.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.5 | 1.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.5 | 2.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.5 | 1.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 0.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.5 | 1.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 0.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.5 | 2.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.5 | 0.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.5 | 2.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 1.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.5 | 1.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.5 | 1.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.5 | 3.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.5 | 0.5 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.5 | 0.9 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 1.4 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.5 | 1.4 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.5 | 0.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 1.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.5 | 2.8 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.5 | 2.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 0.9 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.5 | 3.2 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.4 | 0.9 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.4 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 2.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.4 | 3.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.4 | 1.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 0.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.4 | 2.6 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.4 | 0.9 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.4 | 2.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.4 | 0.4 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.4 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 1.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 3.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.4 | 0.9 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 3.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.4 | 1.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 1.3 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 1.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.4 | 0.8 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.4 | 1.6 | GO:0007135 | meiosis II(GO:0007135) |
0.4 | 1.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.4 | 0.4 | GO:1904851 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.4 | 0.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 2.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 1.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 0.4 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.4 | 0.4 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.4 | 0.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 2.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 1.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 1.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 0.8 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 1.9 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.4 | 1.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 3.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 1.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.4 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 0.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.4 | 0.4 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.4 | 1.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.4 | 1.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.4 | 1.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.4 | 1.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.4 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 3.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 1.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.4 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.4 | 1.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 1.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 0.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 4.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.3 | 4.2 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.3 | 0.7 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.3 | 1.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 3.1 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.3 | 0.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 0.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 1.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 1.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.3 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.3 | 1.0 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 2.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.6 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.3 | 0.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 1.3 | GO:0090102 | cochlea development(GO:0090102) |
0.3 | 1.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
0.3 | 1.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 3.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.3 | 3.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 0.6 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.3 | 0.6 | GO:0043586 | tongue development(GO:0043586) |
0.3 | 3.6 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.6 | GO:1901858 | regulation of mitochondrial DNA replication(GO:0090296) regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.3 | 0.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 0.3 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 0.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.3 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.6 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.3 | 1.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 0.8 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 0.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.3 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.3 | 1.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 1.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 4.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.3 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 0.8 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 2.8 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.3 | 1.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 1.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.5 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 1.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 6.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.7 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.2 | 1.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 1.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 2.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 1.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 1.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 5.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.2 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.2 | 6.4 | GO:0050808 | synapse organization(GO:0050808) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 1.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 9.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 1.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.2 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 10.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 0.2 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.2 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.2 | 0.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.2 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 1.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 2.8 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.2 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 1.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.3 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.2 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.2 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 3.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.9 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 4.0 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 6.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.1 | GO:0010751 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.7 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.1 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 4.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.1 | 1.0 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.6 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.2 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 1.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.4 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 1.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.4 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.3 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 1.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.1 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.6 | 28.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
8.3 | 74.7 | GO:0005883 | neurofilament(GO:0005883) |
7.0 | 28.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
6.7 | 80.5 | GO:0043194 | axon initial segment(GO:0043194) |
5.9 | 17.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
5.9 | 5.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
5.7 | 45.8 | GO:0043083 | synaptic cleft(GO:0043083) |
5.6 | 22.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.6 | 22.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
5.4 | 54.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.6 | 13.8 | GO:0072534 | perineuronal net(GO:0072534) |
4.5 | 13.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
4.0 | 76.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
3.9 | 3.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
3.8 | 22.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.7 | 149.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.7 | 11.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.6 | 21.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
3.5 | 78.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.5 | 21.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
3.4 | 3.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
3.4 | 13.5 | GO:1990696 | USH2 complex(GO:1990696) |
3.3 | 9.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.3 | 29.4 | GO:0036156 | inner dynein arm(GO:0036156) |
3.3 | 9.8 | GO:0033010 | paranodal junction(GO:0033010) |
3.2 | 32.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
3.2 | 86.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.2 | 70.5 | GO:0032590 | dendrite membrane(GO:0032590) |
3.1 | 9.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
3.0 | 12.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
3.0 | 41.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.9 | 14.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.9 | 8.6 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
2.9 | 71.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.8 | 11.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
2.8 | 8.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.7 | 5.4 | GO:1990635 | proximal dendrite(GO:1990635) |
2.6 | 7.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
2.6 | 26.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.5 | 25.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
2.4 | 9.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
2.4 | 134.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.4 | 329.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.4 | 7.2 | GO:0043511 | inhibin complex(GO:0043511) |
2.4 | 2.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
2.4 | 21.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.3 | 7.0 | GO:0097427 | microtubule bundle(GO:0097427) |
2.3 | 28.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
2.2 | 13.3 | GO:0045180 | basal cortex(GO:0045180) |
2.2 | 6.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.2 | 6.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
2.1 | 2.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.1 | 10.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
2.1 | 121.5 | GO:0030175 | filopodium(GO:0030175) |
2.0 | 4.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.0 | 7.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.0 | 23.5 | GO:0031045 | dense core granule(GO:0031045) |
1.9 | 3.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.9 | 5.7 | GO:0000802 | transverse filament(GO:0000802) |
1.9 | 5.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.9 | 3.8 | GO:1990357 | terminal web(GO:1990357) |
1.9 | 7.5 | GO:0032021 | NELF complex(GO:0032021) |
1.8 | 18.5 | GO:0060091 | kinocilium(GO:0060091) |
1.8 | 14.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.8 | 5.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.8 | 3.5 | GO:0043203 | axon hillock(GO:0043203) |
1.7 | 3.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.7 | 8.6 | GO:0097433 | dense body(GO:0097433) |
1.7 | 12.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.7 | 6.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.7 | 8.5 | GO:0070695 | FHF complex(GO:0070695) |
1.6 | 3.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.6 | 4.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.6 | 6.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.5 | 4.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.5 | 5.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.4 | 113.2 | GO:0030426 | growth cone(GO:0030426) |
1.4 | 5.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.4 | 8.6 | GO:0031209 | SCAR complex(GO:0031209) |
1.4 | 8.4 | GO:0032584 | growth cone membrane(GO:0032584) |
1.4 | 8.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.4 | 11.1 | GO:0043198 | dendritic shaft(GO:0043198) |
1.4 | 4.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.3 | 1.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.3 | 194.4 | GO:0098794 | postsynapse(GO:0098794) |
1.3 | 3.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.3 | 16.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.2 | 7.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.2 | 13.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.2 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
1.2 | 2.3 | GO:0033268 | node of Ranvier(GO:0033268) |
1.1 | 9.1 | GO:0097542 | ciliary tip(GO:0097542) |
1.1 | 1.1 | GO:0044308 | axonal spine(GO:0044308) |
1.1 | 3.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.0 | 3.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 7.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.0 | 7.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.0 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
1.0 | 8.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.9 | 126.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.9 | 8.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.9 | 0.9 | GO:0044298 | cell body membrane(GO:0044298) |
0.9 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.9 | 26.7 | GO:0005921 | gap junction(GO:0005921) |
0.9 | 0.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.9 | 2.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.9 | 1.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.9 | 23.4 | GO:0030315 | T-tubule(GO:0030315) |
0.8 | 6.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.8 | 2.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.8 | 9.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 11.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.8 | 0.8 | GO:0044393 | microspike(GO:0044393) |
0.8 | 2.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.8 | 2.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.8 | 11.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 4.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.7 | 8.2 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 9.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 8.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.7 | 2.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 4.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 41.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 3.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 3.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 3.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 1.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.6 | 2.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 1.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 3.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.6 | 1.8 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 3.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.6 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 1.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 4.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 28.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.6 | 2.8 | GO:0071547 | piP-body(GO:0071547) |
0.6 | 1.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 139.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.5 | 3.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 35.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.5 | 14.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.5 | 6.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 0.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.5 | 0.5 | GO:0035838 | growing cell tip(GO:0035838) |
0.5 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 6.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 75.1 | GO:0045202 | synapse(GO:0045202) |
0.4 | 2.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 2.7 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.4 | 1.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.4 | 2.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 1.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 1.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 1.7 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 4.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 2.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 4.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 1.9 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 1.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.3 | 0.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 2.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 0.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 57.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.2 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 1.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.6 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.7 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 3.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 4.4 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 3.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.0 | 63.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
9.1 | 27.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
9.1 | 27.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
8.9 | 26.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
7.5 | 30.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
7.2 | 21.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
7.1 | 35.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
7.0 | 34.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
6.8 | 27.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
6.6 | 26.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
6.5 | 19.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
6.5 | 19.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
6.1 | 18.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
5.9 | 35.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
5.9 | 64.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
5.4 | 16.3 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
5.3 | 10.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
5.2 | 36.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
5.1 | 20.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
5.0 | 15.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.9 | 88.7 | GO:0005112 | Notch binding(GO:0005112) |
4.9 | 24.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
4.9 | 14.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
4.9 | 19.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.9 | 14.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
4.7 | 14.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
4.6 | 22.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
4.5 | 17.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
4.4 | 4.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
4.4 | 8.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
4.4 | 17.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
4.4 | 17.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
4.3 | 13.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
4.2 | 8.5 | GO:0097016 | L27 domain binding(GO:0097016) |
4.2 | 12.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
4.0 | 20.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
4.0 | 128.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
4.0 | 20.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.0 | 15.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
4.0 | 19.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
4.0 | 7.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
3.9 | 35.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
3.8 | 22.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
3.8 | 18.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.7 | 33.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
3.7 | 11.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
3.6 | 47.1 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
3.6 | 14.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
3.5 | 7.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
3.5 | 27.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.4 | 13.6 | GO:0097001 | ceramide binding(GO:0097001) |
3.4 | 13.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
3.4 | 57.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
3.4 | 20.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
3.3 | 16.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
3.2 | 19.4 | GO:0048495 | Roundabout binding(GO:0048495) |
3.2 | 16.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
3.2 | 25.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
3.1 | 9.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.1 | 12.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.1 | 9.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
3.0 | 9.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.0 | 39.5 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
3.0 | 11.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
3.0 | 3.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.9 | 8.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
2.9 | 75.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
2.9 | 20.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.8 | 56.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.8 | 8.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.8 | 8.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.8 | 19.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
2.7 | 16.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
2.6 | 18.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.6 | 21.1 | GO:0034842 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
2.6 | 12.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
2.6 | 7.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.6 | 5.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
2.5 | 17.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.5 | 7.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.5 | 10.0 | GO:0070052 | collagen V binding(GO:0070052) |
2.5 | 40.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
2.4 | 2.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
2.4 | 12.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
2.4 | 17.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.4 | 45.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.4 | 7.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
2.4 | 11.9 | GO:0030506 | ankyrin binding(GO:0030506) |
2.4 | 4.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.4 | 7.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
2.3 | 9.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
2.2 | 8.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.2 | 6.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.2 | 6.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
2.2 | 65.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.2 | 4.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
2.1 | 8.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
2.1 | 17.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.1 | 16.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
2.1 | 2.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.1 | 6.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
2.1 | 4.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
2.1 | 18.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.0 | 4.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.0 | 6.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
2.0 | 6.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.0 | 25.7 | GO:0015026 | coreceptor activity(GO:0015026) |
2.0 | 11.7 | GO:0031005 | filamin binding(GO:0031005) |
1.9 | 5.8 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
1.9 | 9.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.9 | 11.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.9 | 26.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.9 | 20.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.9 | 3.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
1.9 | 26.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.8 | 5.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.8 | 7.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.8 | 7.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.8 | 3.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.8 | 17.9 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.8 | 7.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
1.8 | 33.7 | GO:0005272 | sodium channel activity(GO:0005272) |
1.8 | 7.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.7 | 17.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.7 | 46.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.7 | 24.0 | GO:0030275 | LRR domain binding(GO:0030275) |
1.7 | 6.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.7 | 15.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.7 | 3.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.7 | 6.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.6 | 6.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.6 | 24.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.6 | 17.6 | GO:0015643 | toxic substance binding(GO:0015643) |
1.6 | 1.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.6 | 17.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.6 | 4.7 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.6 | 7.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.6 | 20.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.6 | 4.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.5 | 7.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.5 | 15.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.5 | 6.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.5 | 4.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.5 | 4.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.5 | 7.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.5 | 4.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.4 | 43.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.4 | 10.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.4 | 61.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.4 | 5.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.4 | 7.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.4 | 9.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.4 | 15.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.4 | 9.9 | GO:0046790 | virion binding(GO:0046790) |
1.4 | 11.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.4 | 5.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.4 | 12.6 | GO:0030553 | cGMP binding(GO:0030553) |
1.4 | 12.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.4 | 6.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.4 | 2.7 | GO:0035939 | microsatellite binding(GO:0035939) |
1.4 | 6.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.4 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.4 | 6.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.4 | 6.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.3 | 1.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.3 | 58.1 | GO:0005267 | potassium channel activity(GO:0005267) |
1.3 | 7.9 | GO:0045545 | syndecan binding(GO:0045545) |
1.3 | 16.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.3 | 16.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
1.3 | 6.5 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.3 | 3.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.3 | 26.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.3 | 7.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.3 | 5.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.3 | 5.1 | GO:0034711 | inhibin binding(GO:0034711) |
1.3 | 8.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.2 | 2.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.2 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.2 | 6.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.2 | 19.8 | GO:0003785 | actin monomer binding(GO:0003785) |
1.2 | 17.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.2 | 4.9 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
1.2 | 13.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
1.2 | 11.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.2 | 5.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.2 | 4.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.2 | 5.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.2 | 25.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.2 | 9.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
1.2 | 3.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.2 | 1.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.1 | 3.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.1 | 4.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.1 | 5.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.1 | 13.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.1 | 25.8 | GO:0030507 | spectrin binding(GO:0030507) |
1.1 | 4.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.1 | 3.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 14.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.1 | 9.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.1 | 2.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.1 | 5.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.0 | 3.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.0 | 1.0 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
1.0 | 99.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.0 | 13.1 | GO:0032183 | SUMO binding(GO:0032183) |
1.0 | 17.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.0 | 37.1 | GO:0019111 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
1.0 | 3.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.0 | 2.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.0 | 4.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.0 | 2.9 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.9 | 6.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.9 | 2.8 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.9 | 12.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.9 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.9 | 7.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.9 | 2.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.9 | 14.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 0.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.9 | 9.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.9 | 3.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.9 | 5.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.9 | 18.0 | GO:0043813 | phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.9 | 0.9 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.9 | 22.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.9 | 8.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.9 | 5.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.9 | 2.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.9 | 2.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.8 | 14.8 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.8 | 8.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.8 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 40.0 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.8 | 18.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.8 | 14.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 1.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 2.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.8 | 7.7 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 8.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.8 | 0.8 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.8 | 2.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.8 | 2.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.7 | 5.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.7 | 2.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.7 | 5.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.7 | 7.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 8.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.7 | 1.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 5.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.7 | 4.8 | GO:0043719 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.7 | 13.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 13.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.6 | 3.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 5.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 5.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 3.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.6 | 3.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.6 | 4.1 | GO:0048185 | activin binding(GO:0048185) |
0.6 | 7.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 1.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.6 | 2.9 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.6 | 21.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.6 | 0.6 | GO:0043823 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.6 | 2.3 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.6 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 1.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.6 | 1.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 6.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 0.6 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 2.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 7.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.5 | 1.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 1.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 2.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.5 | 2.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.5 | 7.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 42.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.5 | 2.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 3.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 33.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 10.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.5 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 2.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.5 | 1.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 3.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 2.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 2.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 1.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 1.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 2.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 1.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 7.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.5 | 10.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.5 | 1.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 0.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 1.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 3.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 4.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 1.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 1.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 2.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 2.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 1.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 19.8 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 5.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.4 | 1.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 5.0 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 1.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 0.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.4 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 4.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 4.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.4 | 8.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.4 | 2.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 12.4 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 1.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.4 | 0.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 1.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 6.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.4 | 0.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 2.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 1.5 | GO:0102344 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 3.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 7.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.4 | 4.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 1.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 0.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 1.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 76.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.3 | 1.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 10.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 1.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 3.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 2.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 3.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 3.0 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.3 | 1.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.3 | 3.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 1.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 2.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.1 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 3.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 1.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 1.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 2.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 1.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 97.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 2.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 1.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 3.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 4.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 1.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 3.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.7 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.2 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 4.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 2.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 7.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 13.1 | GO:0008083 | growth factor activity(GO:0008083) |
0.2 | 0.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 12.3 | GO:0005516 | calmodulin binding(GO:0005516) |
0.2 | 4.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 1.1 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.1 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 1.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 1.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 20.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 3.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0015276 | ligand-gated ion channel activity(GO:0015276) ligand-gated channel activity(GO:0022834) |
0.1 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 2.8 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 20.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.0 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 3.4 | GO:0005549 | odorant binding(GO:0005549) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 5.6 | PID IGF1 PATHWAY | IGF1 pathway |
3.8 | 7.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
2.6 | 83.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.3 | 46.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
2.1 | 58.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
2.0 | 10.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.8 | 42.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
1.6 | 1.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.5 | 3.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.5 | 12.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.4 | 41.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.4 | 31.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.4 | 2.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.4 | 52.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.3 | 2.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.3 | 37.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.3 | 19.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.2 | 21.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.1 | 31.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.1 | 6.5 | PID ENDOTHELIN PATHWAY | Endothelins |
1.0 | 21.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.0 | 13.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 48.3 | PID NOTCH PATHWAY | Notch signaling pathway |
1.0 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.9 | 10.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.9 | 14.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 4.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 12.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 7.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 6.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 9.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 94.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.6 | 9.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 22.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 9.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 17.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 107.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 12.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 5.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.5 | 4.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 14.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 108.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 6.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.4 | 3.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 1.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 2.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 6.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 1.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 8.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 7.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 20.1 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 61.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
4.7 | 42.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
4.4 | 34.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
4.1 | 57.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
4.1 | 16.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
3.9 | 58.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
3.7 | 158.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.7 | 3.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
3.6 | 39.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.3 | 3.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
3.3 | 45.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
2.8 | 8.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.8 | 5.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.8 | 73.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.7 | 5.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
2.7 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
2.6 | 26.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.6 | 60.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.5 | 27.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.5 | 35.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.4 | 4.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
2.3 | 25.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.2 | 15.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.2 | 6.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
2.1 | 23.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.1 | 16.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.1 | 77.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
2.0 | 78.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
2.0 | 22.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
2.0 | 45.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.8 | 23.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.7 | 12.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.7 | 38.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.6 | 59.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.5 | 4.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.5 | 34.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.5 | 35.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.4 | 27.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.4 | 11.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.4 | 14.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.4 | 12.8 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
1.4 | 15.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.4 | 8.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.3 | 17.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.3 | 22.8 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
1.3 | 28.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
1.3 | 16.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.2 | 22.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.2 | 23.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.2 | 12.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.2 | 17.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.1 | 12.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.1 | 14.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.1 | 28.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.1 | 7.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.1 | 12.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.0 | 22.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.0 | 1.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.0 | 4.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.0 | 10.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.0 | 14.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.9 | 8.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.9 | 1.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.9 | 10.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.8 | 2.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.8 | 29.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.8 | 7.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.7 | 4.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 10.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.7 | 3.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.7 | 6.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.7 | 34.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.6 | 2.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.6 | 4.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 6.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 11.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 82.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 1.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.5 | 4.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 1.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.5 | 6.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 4.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 6.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.5 | 6.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 5.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 3.4 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 5.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 1.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.4 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 5.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 9.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 4.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 3.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.3 | 5.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 3.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 0.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.3 | 1.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 16.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 5.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 6.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 5.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 4.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 2.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |